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Abstract
Background: Cholera is an important infectious cause of secretory diarrhea. The primary symptom of infection is the sudden
onset of watery diarrhea with subsequent volume depletion causing renal insufficiency. The objective of this research is to
study the level of dehydration at presentation and subsequent fluid management in patients with cholera.
Methods: This study was conducted on 191 patients of Cholera admitted at a tertiary care hospital in Karachi, Pakistan
during the period of 5 years. Medical charts were evaluated retrospectively for initial hydration status, baseline lab
investigations on admission and discharge and fluid therapy given to all the patients while their stay in the hospital and the
data was analyzed on SPSS 15.0.
Results: Out of the 191 patients, 83(43%) were males and 108 (57%) were females with mean age of 42.3 years (SD618.34).
The average duration of symptoms was 3.75 days (SD62.04). Of 191 patients, 175 (92.1%) presented with dehydration, 80
(42.3%) were given Ringer’s Lactate (R/L) + Normal Saline (N/S), 45 (24%) patients were given R/L + N/S + Oral Rehydration
Therapy (ORS), 27 (14.3%) of the patients were kept on R/L only and remaining were given various combinations of R/L, N/S,
ORS and Dextrose Saline (D/S). On admission mean Blood Urea Nitrogen (BUN) was 24.54 (SD616.6), mean creatinine was
2.47 (SD62.35) and mean BUN/Creatinine ratio was 11.63 (SD65.7).
Conclusion: Aggressive fluid rehydration remains the cornerstone of management of cholera. Instead of presenting with a
classical BUN/Creatinine ratio of .20:1, patients with pre-renal failure in cholera may present with a BUN/Creatinine ratio of ,15:1.
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Introduction
Cholera has long been known as a cause of diarrhea [1]. This
acute diarrheal illness is caused by certain serotypes of Vibrio
Cholerae [2]. V. cholerae is traditionally classified by O group (with
.150 O types currently recognized in the widely used Sakazaki
grouping system) and by biotype (classical and El Tor) and serotype
(Ogawa, Inaba, and, rarely, Hikojima)[3]. Contaminated food and
water is the mode of transmission for this infection [4]. It causes
massive fluid loss by toxin mediated hypersecretion of water and
chloride ion [5]. The incubation period of cholera can range from
several hours to 5 days [6]. The common symptom associated with
choleraisacute,painless,voluminous,waterydiarrheaandeffortless
vomiting, the diarrhea is sometimes referred as ‘‘rice water
stools’’[7,8]. It is diagnosed by Stool culture and agglutination of
vibrios with specific sera [9]. The treatment management of cholera
revolves around the oral or Intravenous (I/V) replenishment of the
lost fluid, which is the mainstay therapy for these patients [10,11].
Antimicrobial therapy shortens the course of the illness. Several
active antibiotics against V. Cholera have been used including
tetracycline, ampicillin, ciprofloxacin and trimethoprim- sulfameth-
oxazole [12]. Untreated cholera cases can have fatality rates above
50% [13]. The objective of our study is to determine the BUN/
Creatinine ratio in cholera patients with dehydration and renal
insufficiency and amount of fluid replacement therapy given in a
tertiary care hospital in Pakistan.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Ethics Review Committee of the Department of Medicine of the
Aga Kahn University.
Methods
Medical records of 191 patients diagnosed with Cholera in the
last 5 years at Aga Khan University Hospital, Karachi, were
evaluated retrospectively. Patients included in the study were
identified using proper diagnostic criteria which included patients
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positive lab cultures.
Medical charts were evaluated for baseline investigation
including initial hydration status, BUN on admission, creatinine
on admission, BUN/creatinine ratio on admission, severity of the
illness on presentation, and in- hospital investigation which
included 24 hourly fluid administration, types of fluid adminis-
trated, hydration status on discharge, BUN on discharge,
creatinine on discharge, BUN/creatinine ratio on discharge,
duration of hospital stay, causative agents (serotype), stool cultures
and clinical outcome of the patients.
The data was analyzed using SPSS 15.0 using basic frequencies
and chi-squares to define the p-values.
Results
Out of the 191 patients 83 (43%) were males and 108 (57%)
were females with mean age of 42.3618.34 years. The average
duration of symptoms was 3.75 (SD62.04) days. From all the
patients, 175 (92.1%) presented with dehydration and of those,
7.5% (14), 62.0% (116), 30.5%(57) fell in the clinical category of
mild, moderate and severe dehydration respectively. Mean
hospital stay of the patients was 3.83 days (SD62.785). Among
species, majority were found to belong to the Ogawa species
75.7% (137) followed by 0139 species 24.3% (44). Rectal tube was
used in 94.1% (174) of the patients during the hospital stay to
monitor fluid loss. A total of 189 patients were treated with
antibiotics during the course. 31.4% (60) patients developed acute
renal failure as a complication which resolved at an average of 2.1
days (SD63.3).
Regarding fluid resuscitation, 80 (42.3%) were given R/L +
N/S, 45 (24%) patients were given R/L + N/S + ORS, 27 (14.3%)
of the patients were kept on R/L only and remaining were given
various combinations of R/L, N/S, ORS and D/S. (See Table 1).
An average of 24826 mL (SD615998) was given to the patients
under fluid therapy during an average stay of 3.8 days (SD62.8).
9998.5 mL (SD65252) was the average fluid administered during
first day of hospital stay. (See Table 2).
On admission, mean BUN was 24.54 (SD616.6), mean
creatinine was 2.47 (SD62.35) and mean BUN/Creatinine ratio
on was 11.63 (SD65.7). On Discharge average BUN was 11.97
(SD610.81) and average Creatinine on discharge was 1.18
(SD61.28). At presentation, the BUN/Creatinine ratio of patients
who developed Acute Renal Failure (ARF) was significantly lower
than the BUN/Creatinine ratio of the patients without ARF (p
value 0.04). However, the ratio was not significantly different at
discharge (p value 0.81). No patient expired during the hospital
stay. (See Table 3)
Discussion
Cholera still remains a cause of severe diarrhea in third world
countries with poor sanitation conditions. It remained one of the
common cause of mortality until late 1960s when the role of ORT
(oral rehydration therapy) was established after the discovery of
intact sodium-glucose intestinal co-transporter [12]. The disease is
characterized by a devastating watery diarrhea which leads to
rapid dehydration, and death occurs in 50 to 70% of untreated
patients [14]. Despite availability of Oral Rehydration therapy for
more than 3 decades the severity of diarrhea in Cholera can be
estimated from 2.5 million deaths claimed per year globally [15].
The main cause of death in patients with cholera is hypovolemic
shock caused by severe dehydration.
As a result of intravascular fluid depletion and decreased
effective circulating volume, the blood flow to kidneys is impaired
and this leads to Pre-renal failure. Pre-renal failure can be
distinguished from Intra- renal failure by BUN to creatinine ratio,
Fractional excretion of Sodium and Fractional Excretion of Urea
nitrogen [16]. In Pre- renal failure the BUN to creatinine ratio
rises from a normal level of 10:1 to more than 20:1. As we see in
our study the average fluid deficit replaced in 3.83 days was
around 25 liters but even with such deficit we noticed that the
patients had an average BUN to creatinine ratio of 11.63 at the
time of hospital admission. The outcome of Pre-renal failure is its
rapid response to fluid therapy, and in our study the average
serum creatinine on admission was 2.47 which came down to 1.18
at the time of discharge. Table 1. Type of fluid therapy adminstered.
Frequency Percent
N/S 7 3.7
R/L 27 14.1
R/L+ORS 19 9.9
R/L+N/S 80 41.9
N/S+ORS 5 2.6
N/S,D/S,R/L 3 1.6
N/S+R/L+ORS 45 23.6
D/S+R/L 3 1.6
ORS 2 1.0
Total 191 100.0
N/S = Normal saline.
R/L = Ringer’s lactate.
ORS = Oral Rehydration Solution.
D/S = Dextrose Saline.
doi:10.1371/journal.pone.0007552.t001
Table 2. Quantity of fluids given.
Minimum Maximum Mean Std. Deviation
Fluids given in 1st 24 hrs 1800.0 38000.0 9998.5 5252.1
Total fluids administered 1800.0 40250.0 24826.8 15998.0
doi:10.1371/journal.pone.0007552.t002
Table 3. Blood Urea Nitrogen and Creatinine levels and
ratios.
Minimum Maximum Mean Std. Deviation
BUN
On Admission 3.0 132.0 24.5 16.6
At Discharge 1.0 78.0 12.0 10.8
Creatinine
On Admission 0.5 25.0 2.5 2.4
At Discharge 0.5 10.0 1.2 1.3
BUN Creatinine Ratio
on Admission
1.0 31.4 11.6 5.7
BUN Creatinine Ratio
on Discharge
0.57 42 11.72 7.9
doi:10.1371/journal.pone.0007552.t003
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volume depletion) is that it is due to increased tubular urea
reabsorption, so the urea clearance falls more than the creatinine
clearance. There is also an effect of anti-diuretic hormone, which
promotes urea reabsorption.
The 20:1 rule for BUN/Creatinine ratio in pre renal failure
may only be an approximation – there may be lots of exceptions. It
is more reliable if the patient is in a fairly steady state, rather than
having a very acute problem. The increase in BUN with
dehydration takes a while – perhaps these patients are so acutely
dehydrated that they have not had enough time for the urea to
reach equilibrium. We think this is the most important reason that
the BUN/creatinine ratio is not higher. Also availability of
Fractional Excretion of Sodium (FeNa) would have made the
analysis more clear.
The baseline BUN/Creatinine ratio must also be important,
and it would be lower than usual if these patients are consuming
low protein intakes. We realize that the ratio was 10 at discharge,
but it might have fallen further in a few more days.
Finally, it may be possible if urea is lost from the gut more
rapidly than creatinine in cholera.
Further larger prospective studies are needed to study urea
metabolism in pre-renal failure in cholera and the effects of
cholera toxin on intestinal urea transport.
Limitations of the study included a small sample size from a
tertiary care hospital, which was not at all representative of the
general population. As it was a retrospective study, due to
unavailability of all records, there was an inability to analyze
electrolytes and there relation with the BUN/Creatinine ratio for
the development of pre renal failure. Further well designed
prospective studies of larger sample size need to address these
limitations.
From this study we conclude that the role of rapid and
aggressive fluid therapy remains crucial not only as a life saving
measure in the management of Cholera but rapid fluid therapy
may reverse the impending acute renal failure caused by severe
dehydration. Moreover, the classical BUN/Creatinine ratio for
pre renal failure of .20:1 is missing in our patients, and they may
present with a BUN/Creatinine ratio of ,15:1.
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